Implantable neurostimulation devices market to reach $13.13b by 2028

Its growth is attributed to the rising incidence of neurological disorders.

The implantable neurostimulation devices market is projected to reach $13.13b by 2028 at a compound annual growth rate of 10.9%, said Research and Markets.

The sector’s expansion is attributed to the rising incidence of neurological disorders, lifestyle-related diseases, and spinal cord injuries. A greater awareness and increased healthcare expenditure is also driving this growth.

“Implantable neurostimulation devices are utilised to modulate nerve activity and alleviate symptoms when other treatments prove ineffective or insufficient,” the report said.

Meanwhile, key market trends include advancements in sensing and neurostimulation technologies, the development of closed-loop systems, and the integration of wireless technology.